Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Liver Transpl. 2011 Jun;17(6):723–732. doi: 10.1002/lt.22266

Table 3.

Proteins which are decreased in patients with ACR in comparison with NO-ACR patients.

Protein Fold decrease
Human Apolipoprotein C-I 0.80 ± 0.02
Nuclear protein 0.72 ± 0.11
Zn-alpha2-glycoprotein 0.63 ± 0.12
Apolipoprotein B-100 0.46 ± 0.09
Apolipoprotein-H 0.46 ± 0.03
Serine (or cysteine) proteinase inhibitor 0.36 ± 0.21
Ribosomal protein L15 0.31 ± 0.02
Apolipoprotein D 0.26 ± 0.32
Adenylate kinase 7 0.26 ± 0.02
Plasma protease C1 inhibitor precursor (C1 Inh) 0.23 ± 0.11
Beta-2-glycoprotein I precursor 0.21 ± 0.04
Insulin-like growth factor binding protein 0.17 ± 0.06
Ribonucleoprotein autoantigen 60 kd subunit 0.12 ± 0.04